Log in

NYSE:NTRNutrien Competitors & Alternatives

$33.24
+1.48 (+4.66 %)
(As of 07/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$32.55
Now: $33.24
$33.56
50-Day Range
$31.26
MA: $34.68
$39.07
52-Week Range
$23.85
Now: $33.24
$55.25
Volume1.64 million shs
Average Volume1.38 million shs
Market Capitalization$18.94 billion
P/E Ratio21.17
Dividend Yield5.67%
Beta0.86

Competitors

Nutrien (NYSE:NTR) Vs. SMG, CF, MOS, AVD, MBII, and CLXT

Should you be buying NTR stock or one of its competitors? Companies in the industry of "agricultural chemicals" are considered alternatives and competitors to Nutrien, including Scotts Miracle-Gro (SMG), CF Industries (CF), Mosaic (MOS), American Vanguard (AVD), Marrone Bio Innovations (MBII), and Calyxt (CLXT).

Scotts Miracle-Gro (NYSE:SMG) and Nutrien (NYSE:NTR) are both basic materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations.

Earnings and Valuation

This table compares Scotts Miracle-Gro and Nutrien's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scotts Miracle-Gro$3.16 billion2.44$460.70 million$4.4731.10
Nutrien$20.02 billion0.95$992 million$2.1715.32

Nutrien has higher revenue and earnings than Scotts Miracle-Gro. Nutrien is trading at a lower price-to-earnings ratio than Scotts Miracle-Gro, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Scotts Miracle-Gro and Nutrien's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Scotts Miracle-Gro9.49%42.92%8.99%
Nutrien4.49%4.66%2.27%

Dividends

Scotts Miracle-Gro pays an annual dividend of $2.32 per share and has a dividend yield of 1.7%. Nutrien pays an annual dividend of $1.80 per share and has a dividend yield of 5.4%. Scotts Miracle-Gro pays out 51.9% of its earnings in the form of a dividend. Nutrien pays out 82.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Scotts Miracle-Gro has increased its dividend for 10 consecutive years and Nutrien has increased its dividend for 1 consecutive years.

Insider & Institutional Ownership

63.1% of Scotts Miracle-Gro shares are held by institutional investors. Comparatively, 61.9% of Nutrien shares are held by institutional investors. 28.2% of Scotts Miracle-Gro shares are held by company insiders. Comparatively, 3.1% of Nutrien shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Volatility and Risk

Scotts Miracle-Gro has a beta of 0.93, meaning that its share price is 7% less volatile than the S&P 500. Comparatively, Nutrien has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations for Scotts Miracle-Gro and Nutrien, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Scotts Miracle-Gro03302.50
Nutrien061512.77

Scotts Miracle-Gro currently has a consensus target price of $124.80, indicating a potential downside of 10.22%. Nutrien has a consensus target price of $49.30, indicating a potential upside of 48.32%. Given Nutrien's stronger consensus rating and higher possible upside, analysts plainly believe Nutrien is more favorable than Scotts Miracle-Gro.

Summary

Scotts Miracle-Gro beats Nutrien on 11 of the 18 factors compared between the two stocks.

CF Industries (NYSE:CF) and Nutrien (NYSE:NTR) are both basic materials companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, profitability, risk and analyst recommendations.

Dividends

CF Industries pays an annual dividend of $1.20 per share and has a dividend yield of 4.0%. Nutrien pays an annual dividend of $1.80 per share and has a dividend yield of 5.4%. CF Industries pays out 62.2% of its earnings in the form of a dividend. Nutrien pays out 82.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Nutrien has increased its dividend for 1 consecutive years. Nutrien is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Insider and Institutional Ownership

92.4% of CF Industries shares are held by institutional investors. Comparatively, 61.9% of Nutrien shares are held by institutional investors. 2.0% of CF Industries shares are held by insiders. Comparatively, 3.1% of Nutrien shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profitability

This table compares CF Industries and Nutrien's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CF Industries10.33%8.34%3.73%
Nutrien4.49%4.66%2.27%

Valuation and Earnings

This table compares CF Industries and Nutrien's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CF Industries$4.59 billion1.39$493 million$1.9315.41
Nutrien$20.02 billion0.95$992 million$2.1715.32

Nutrien has higher revenue and earnings than CF Industries. Nutrien is trading at a lower price-to-earnings ratio than CF Industries, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent recommendations and price targets for CF Industries and Nutrien, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CF Industries191002.45
Nutrien061512.77

CF Industries currently has a consensus price target of $44.0588, indicating a potential upside of 48.10%. Nutrien has a consensus price target of $49.30, indicating a potential upside of 48.32%. Given Nutrien's stronger consensus rating and higher possible upside, analysts plainly believe Nutrien is more favorable than CF Industries.

Volatility & Risk

CF Industries has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500. Comparatively, Nutrien has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500.

Summary

Nutrien beats CF Industries on 11 of the 18 factors compared between the two stocks.

Mosaic (NYSE:MOS) and Nutrien (NYSE:NTR) are both basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, institutional ownership, profitability and analyst recommendations.

Risk and Volatility

Mosaic has a beta of 1.72, meaning that its stock price is 72% more volatile than the S&P 500. Comparatively, Nutrien has a beta of 0.86, meaning that its stock price is 14% less volatile than the S&P 500.

Earnings and Valuation

This table compares Mosaic and Nutrien's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mosaic$8.91 billion0.55$-1,067,400,000.00$0.1968.16
Nutrien$20.02 billion0.95$992 million$2.1715.32

Nutrien has higher revenue and earnings than Mosaic. Nutrien is trading at a lower price-to-earnings ratio than Mosaic, indicating that it is currently the more affordable of the two stocks.

Dividends

Mosaic pays an annual dividend of $0.20 per share and has a dividend yield of 1.5%. Nutrien pays an annual dividend of $1.80 per share and has a dividend yield of 5.4%. Mosaic pays out 105.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Nutrien pays out 82.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Mosaic has raised its dividend for 1 consecutive years and Nutrien has raised its dividend for 1 consecutive years. Nutrien is clearly the better dividend stock, given its higher yield and lower payout ratio.

Profitability

This table compares Mosaic and Nutrien's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Mosaic-15.91%-0.53%-0.26%
Nutrien4.49%4.66%2.27%

Analyst Ratings

This is a summary of recent ratings and target prices for Mosaic and Nutrien, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Mosaic08802.50
Nutrien061512.77

Mosaic presently has a consensus price target of $17.00, indicating a potential upside of 31.27%. Nutrien has a consensus price target of $49.30, indicating a potential upside of 48.32%. Given Nutrien's stronger consensus rating and higher possible upside, analysts clearly believe Nutrien is more favorable than Mosaic.

Insider and Institutional Ownership

72.9% of Mosaic shares are owned by institutional investors. Comparatively, 61.9% of Nutrien shares are owned by institutional investors. 0.5% of Mosaic shares are owned by company insiders. Comparatively, 3.1% of Nutrien shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Nutrien beats Mosaic on 15 of the 17 factors compared between the two stocks.

Nutrien (NYSE:NTR) and American Vanguard (NYSE:AVD) are both basic materials companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings and risk.

Insider & Institutional Ownership

61.9% of Nutrien shares are owned by institutional investors. Comparatively, 79.6% of American Vanguard shares are owned by institutional investors. 3.1% of Nutrien shares are owned by insiders. Comparatively, 5.3% of American Vanguard shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Nutrien and American Vanguard's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Nutrien4.49%4.66%2.27%
American Vanguard2.20%3.03%1.52%

Risk and Volatility

Nutrien has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500. Comparatively, American Vanguard has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Nutrien and American Vanguard, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Nutrien061512.77
American Vanguard00103.00

Nutrien presently has a consensus target price of $49.30, suggesting a potential upside of 48.32%. American Vanguard has a consensus target price of $19.00, suggesting a potential upside of 41.79%. Given Nutrien's higher probable upside, equities research analysts plainly believe Nutrien is more favorable than American Vanguard.

Dividends

Nutrien pays an annual dividend of $1.80 per share and has a dividend yield of 5.4%. American Vanguard pays an annual dividend of $0.08 per share and has a dividend yield of 0.6%. Nutrien pays out 82.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. American Vanguard pays out 17.4% of its earnings in the form of a dividend. Nutrien has raised its dividend for 1 consecutive years and American Vanguard has raised its dividend for 2 consecutive years.

Earnings & Valuation

This table compares Nutrien and American Vanguard's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nutrien$20.02 billion0.95$992 million$2.1715.32
American Vanguard$468.19 million0.86$13.60 million$0.4629.13

Nutrien has higher revenue and earnings than American Vanguard. Nutrien is trading at a lower price-to-earnings ratio than American Vanguard, indicating that it is currently the more affordable of the two stocks.

Summary

Nutrien beats American Vanguard on 11 of the 18 factors compared between the two stocks.

Nutrien (NYSE:NTR) and Marrone Bio Innovations (NASDAQ:MBII) are both basic materials companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, dividends, institutional ownership and risk.

Analyst Ratings

This is a summary of recent ratings for Nutrien and Marrone Bio Innovations, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Nutrien061512.77
Marrone Bio Innovations00303.00

Nutrien presently has a consensus price target of $49.30, suggesting a potential upside of 48.32%. Marrone Bio Innovations has a consensus price target of $1.8833, suggesting a potential upside of 77.67%. Given Marrone Bio Innovations' stronger consensus rating and higher possible upside, analysts clearly believe Marrone Bio Innovations is more favorable than Nutrien.

Institutional & Insider Ownership

61.9% of Nutrien shares are held by institutional investors. Comparatively, 35.0% of Marrone Bio Innovations shares are held by institutional investors. 3.1% of Nutrien shares are held by company insiders. Comparatively, 3.4% of Marrone Bio Innovations shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Nutrien and Marrone Bio Innovations' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nutrien$20.02 billion0.95$992 million$2.1715.32
Marrone Bio Innovations$29.37 million5.25$-37,170,000.00($0.21)-5.05

Nutrien has higher revenue and earnings than Marrone Bio Innovations. Marrone Bio Innovations is trading at a lower price-to-earnings ratio than Nutrien, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Nutrien has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500. Comparatively, Marrone Bio Innovations has a beta of 0.28, indicating that its stock price is 72% less volatile than the S&P 500.

Profitability

This table compares Nutrien and Marrone Bio Innovations' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Nutrien4.49%4.66%2.27%
Marrone Bio Innovations-132.76%-136.82%-37.67%

Summary

Nutrien beats Marrone Bio Innovations on 11 of the 15 factors compared between the two stocks.

Calyxt (NASDAQ:CLXT) and Nutrien (NYSE:NTR) are both consumer staples companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations and profitability.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Calyxt and Nutrien, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Calyxt04102.20
Nutrien061512.77

Calyxt presently has a consensus price target of $7.00, suggesting a potential upside of 50.86%. Nutrien has a consensus price target of $49.30, suggesting a potential upside of 48.32%. Given Calyxt's higher probable upside, equities research analysts plainly believe Calyxt is more favorable than Nutrien.

Profitability

This table compares Calyxt and Nutrien's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Calyxt-455.07%-64.78%-47.52%
Nutrien4.49%4.66%2.27%

Earnings and Valuation

This table compares Calyxt and Nutrien's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Calyxt$7.30 million21.00$-39,610,000.00($1.21)-3.83
Nutrien$20.02 billion0.95$992 million$2.1715.32

Nutrien has higher revenue and earnings than Calyxt. Calyxt is trading at a lower price-to-earnings ratio than Nutrien, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Calyxt has a beta of 2.41, meaning that its share price is 141% more volatile than the S&P 500. Comparatively, Nutrien has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500.

Institutional and Insider Ownership

23.9% of Calyxt shares are owned by institutional investors. Comparatively, 61.9% of Nutrien shares are owned by institutional investors. 2.3% of Calyxt shares are owned by insiders. Comparatively, 3.1% of Nutrien shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Nutrien beats Calyxt on 12 of the 15 factors compared between the two stocks.

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Scotts Miracle-Gro logo
SMG
Scotts Miracle-Gro
2.0$139.01+0.0%$7.72 billion$3.16 billion24.35
CF Industries logo
CF
CF Industries
2.4$29.75+5.5%$6.01 billion$4.59 billion13.97Dividend Announcement
Analyst Upgrade
Heavy News Reporting
Mosaic logo
MOS
Mosaic
2.3$12.95+5.0%$4.66 billion$8.91 billion-3.52
American Vanguard logo
AVD
American Vanguard
2.5$13.40+0.8%$400.82 million$468.19 million37.22
Marrone Bio Innovations logo
MBII
Marrone Bio Innovations
1.3$1.06+1.9%$157.17 million$29.37 million-3.21
Calyxt logo
CLXT
Calyxt
1.7$4.64+2.4%$153.31 million$7.30 million-3.52
CVR Partners logo
UAN
CVR Partners
1.3$0.86+4.7%$92.89 million$404.18 million-2.00
Arcadia Biosciences logo
RKDA
Arcadia Biosciences
1.3$3.67+3.3%$38.08 million$1.17 million-2.25
Evogene logo
EVGN
Evogene
0.6$1.00+2.0%$25.75 million$750,000.00-1.25
CGA
China Green Agriculture
0.8$2.60+5.8%$17.46 million$294.32 million0.00
SenesTech logo
SNES
SenesTech
0.6$1.99+1.0%$6.69 million$140,000.00-0.26
ICL Group logo
ICL
ICL Group
1.2$3.09+1.9%$0.00$5.27 billion9.97High Trading Volume
Analyst Revision
This page was last updated on 7/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.